Mice transplanted with CD24−/CD44+‐breast CSCs exhibited a significant increase in tumor size (Figure 4A) and weight (Figure 4B) as compared with that of CD24+‐breast cancer cells, suggesting the high tumorigenic potential of breast CSCs as compared to cancer cells. This evidence concerns the gene CD44 and breast carcinoma.